14.75 (-%)
As of Nov 21, 2024
Source:
Oculis Holding Ag is a clinical-stage biopharmaceutical company, based in Switzerland, with substantial expertise in therapeutics used to treat ocular diseases, and engaged in the development of innovative drug candidates which have the potential to address many currently eye-related conditions.
| Country | Switzerland |
| Headquarters | zug |
| Phone Number | 617-937-2423 |
| Industry | |
| CEO | Riad Sherif |
| Website | oculis.com |